Amicus Therapeutics, Inc. (FOLD) Message Board
-
Those lawsuits will only make the lawyers rich. It is not worth it plus we'll be back to $5-$6 range once the mgmt announces the plans going forward for Tivo, which I believe will happen by the end of summer.
Sentiment: Buy
- Reply to
IR officer told me that FDA considering a new data analysis to avoid a new expensive P3
by taexpert928 •May 13, 2013 4:43 PMThat is material information! I don't think this is a kind of info an IR officer can give to an investor over the phone without sending a PR first. I sure hope it is right but I don't believe it!
Sentiment: Buy
-
This is wonderful. It is well worth the read. If the drug is that beneficial to kidney cancer patients why don't they bug FDA with emails, visits, letters, etc.? There are still over two months to PDUFA decision. It is unprecedented for FDA to approve a drug with this wide margin of NOs but you never know ...
Sentiment: Buy
-
is there a good site to check iron ore prices real-time? thanks.
Sentiment: Buy
-
I don't see any open market buys. They are all options. Means nothing.
Sentiment: Buy
-
Thanks a lot for taking your time to write these messages. This is a lot of information for me to digest and looks like you know what you are doing. I will visit your site from time to time.
-
stockineer, you said your favorites are inverse head and shoulders and double bottoms. I am sure you keep track of your trades made by those two patterns. Can you share your track record on those trades? I am not a believer in TA but I find it intriguing nonetheless.
Sentiment: Buy
-
A rejection is already priced in for AVEO. So it won't have any effect. Just my 2 cents.
Sentiment: Buy
-
I agree that he should be fired. If he has a little respect for himself he should resign now but I doubt that he will.
Sentiment: Buy
-
The stock trades. that is the only verification you need...
-
It is not halted. The stock trades.
Sentiment: Buy
-
I don't see it in NASDAQ site. Where do you see it?
Sentiment: Buy
-
This company made $11/share in 2011. Analyst crushed estimates down to $1.8 because they factored in the worst case scenario. Imagine what will happen to EPS if things turn a bit. Right now most global indicators are trending positively. What will those analysts do if CLF announces $1/share next quarter? If investing in a stock was as easy as looking into EPS and deciding whether a stock is cheap or not everybody (including you) will be rich by now.
Sentiment: Buy
-
On 5/7/13, CLF announced a regular quarterly cash dividend of $0.15 per share, payable on 6/3/13 to shareholders, with an ex-dividend date of 5/15/13.
I think this will continue its uptrend until mid May.Sentiment: Buy
-
Where do you monitor iron ore features?
- Reply to
Been telling you that shorts were going to get creampuffed and...
by velvet_revolvah •May 8, 2013 7:47 PMSo far so good but all it will take to reverse this trend is a news from China about how their economy got stalled. We are seeing some encouraging signs in the global markets about economy getting back on track. I agree that with more positive news coming in we will see $35-$40 in a month. There are still a lot of retail investors waiting on the sidelines scratching their heads. So we need more evidence of improving economic activity across the world before we can get more excited.
Sentiment: Buy
-
It is up because it was oversold. Let see if this bounce has legs.
Sentiment: Buy
- Reply to
Rumor: Astella is about to buy AVEO after it acquired OSI in June 2010 to add oncology infrastructure
by taexpert928 •May 6, 2013 1:36 PMRetail investors will be happy for $4 but there are institutional investors who are in this for the long haul and who are invested because they saw the value in TIVO. Just my 2cents. I will be happy for $4 too.
Sentiment: Buy
- Reply to
Rumor: Astella is about to buy AVEO after it acquired OSI in June 2010 to add oncology infrastructure
by taexpert928 •May 6, 2013 1:36 PMI don't think shareholders will approve $4. Maybe $6 but certainly not $4.
Sentiment: Buy
-
Looks like short-term bottom is in.
Sentiment: Buy